First results of a phase I/II dose escalation trial in non-small cell lung cancer using three-dimensional conformal radiotherapy
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 66 (2) , 119-126
- https://doi.org/10.1016/s0167-8140(02)00377-8
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Preoperative Staging of Non–Small-Cell Lung Cancer with Positron-Emission TomographyNew England Journal of Medicine, 2000
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999
- Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patientsLung Cancer, 1999
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- 489 Normal tissue complication probabilities for irradiation of NSCLC patients with and without elective nodal irradiationLung Cancer, 1997
- Endpoints for multimodal clinical trials in Stage III non-small cell lung cancer (NSCLC): a consensus reportLung Cancer, 1994
- A verification procedure to improve patient set-up accuracy using portal imagesRadiotherapy and Oncology, 1993
- Three-dimensional conformal radiation therapy at the Memorial Sloan-Kettering Cancer CenterSeminars in Radiation Oncology, 1992
- Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung CancerNew England Journal of Medicine, 1992
- Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancerRadiotherapy and Oncology, 1988